Vimarsana
Biggest News Aggregation in the World

Adenomas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adenomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adenomas Today - Breaking & Trending Today

Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study - Vimarsana News

Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study

Author summary Why was this study done? ➢ The burden of colorectal cancer (CRC) in China has been growing in recent years. ➢ More specific selection of individuals to undergo colonoscopy, based on both questionnaire-based risk assessment and fecal immunochemical test (FIT) results, could result in more efficiency allocation of colonoscopy resources. ➢ There is limited evidence on the colonoscopy screening yield when combining FITs and risk assessment through questionnaires. What did the researchers do and find? ➢ We calculated the baseline screening yield, participation, and cost...

Source: plos.org
Incidence of CRC Increased in Male Patients Younger Than 50 Years - Vimarsana News

Incidence of CRC Increased in Male Patients Younger Than 50 Years

Although the incidence of colorectal cancer (CRC) decreased in individuals older than 50 years, incidence of CRC increased in male individuals younger than 50 years.

Source: ajmc.com
Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study) - Vimarsana News

Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)

In a randomized trial Natalia González-López and co-workers investigate whether fecal immunochemical testing improves screening uptake in first degree relatives of patients with non-syndromic colorectal cancer.

Source: plos.org
Health Take-Away: Colonoscopies save lives; prevention is better than a cure - Vimarsana News

Health Take-Away: Colonoscopies save lives; prevention is better than a cure

In the fight against colon cancer, the No. 1 goal is not making the diagnosis and treating the disease. It is prevention. Although it is one of the easiest types of cancer to prevent through routine screening, over 50,000 people die from colon cancer every year in the U.S., making it the second-leading cause of cancer death in men and the third most common in women. More than half of those deaths could be prevented by a relatively simple, painless screening examination called a colonoscopy — and yet, one in every three Americans over the age of 50 chooses to never undergo any type of col...

Detailed text transcripts for TV channel - CNN - 20100810:22:16:00 - Vimarsana News

Detailed text transcripts for TV channel - CNN - 20100810:22:16:00

Down? >> that is it. >> reporter: and they patted you on the head and said just calm down. >> yes. >> reporter: my mother did not question her doctor. were you an empowered patient? >> no, i was unempowered in this process. i was empowered mother, and social worker and teacher, but i was not an empowered patient. >> reporter: did you just trust the doctors? >> that is what i was brought up to do. >> reporter: a good girl from the '50s? >> from the '40s. >> reporter: then one day my mother flew in to visit me from atlanta, and i could tell she felt awful. do you remember what we did there? >> y...